Shares of Radius Health Trading Down 9%; 8-K Filing from Co. Last Night Showed In July '15 FDA Denied Re-Submitted Request for Breakthrough Designation for Abaloparatide-SC, Says Evaluating Options for Another Resubmission
Paul Quintaro